Filana Therapeutics
FLNA
163 hedge funds and large institutions have $390M invested in Filana Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 52 reducing their positions, and 28 closing their positions.
4% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 52
2.57% less ownership
Funds ownership: 28.82% → 26.25% (-2.6%)
5% less funds holding
Funds holding: 171 → 163 (-8)
22% less capital invested
Capital invested by funds: $503M → $390M (-$113M)
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
39% less call options, than puts
Call options by funds: $107M | Put options by funds: $175M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
+$6.02M |
| 2 |
State Street
Boston,
Massachusetts
|
+$3.3M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$2.94M |
| 4 |
D.E. Shaw & Co
New York
|
+$1.88M |
| 5 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
+$1.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$17.2M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$10.4M |
| 3 |
Jane Street
New York
|
-$4.06M |
| 4 |
Barclays
London,
United Kingdom
|
-$3.68M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.65M |
FLNA Hedge Fund Activity: Q1 2022 in Review
163 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q1 2022, worth a combined $390M — down 22% from $503M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of FLNA and 21 opened new positions — a net loss of 7 holders — while 52 trimmed existing stakes and 50 added.
The largest buyer was Group One Trading, adding an estimated $6.02M. The largest seller was Morgan Stanley, cutting an estimated $17.2M.
- 163 institutional investors held Filana Therapeutics (FLNA) as of Q1 2022, down from 171 in Q4 2021.
- Funds reported $390M of Filana Therapeutics stock for Q1 2022, down 22% quarter-over-quarter.
- 21 funds opened new Filana Therapeutics positions in Q1 2022 and 28 closed out, a net change of -7 holders.
- The largest Filana Therapeutics buyer in Q1 2022 was Group One Trading, an estimated $6.02M added.
- The largest Filana Therapeutics seller in Q1 2022 was Morgan Stanley, an estimated $17.2M sold.
Based on aggregated 13F filings for Q1 2022.